CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 318 enrolled
Drug / intervention
Dexamethasone Sodium Phosphate Injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02192827
NCT02192827Phase 3Completed
CompareCT.gov

Single Dose Dexamethasone is as Effective as Two Doses in Mild to Moderate Pediatric Asthma Exacerbations in the Emergency Department

University at Buffalo·interventional·Posted Jul 17, 2014·Updated Mar 30, 2023

In Brief

A Phase 3 clinical trial evaluating Dexamethasone Sodium Phosphate Injection for Asthma. Completed, enrolled 318 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the efficacy of a single dose of dexamethasone vs. two doses of dexamethasone in mild and moderate asthma exacerbations pediatric patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 17, 2014
Enrollment StartApr 1, 2015
Primary CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.0 years ago

Interventions

Dexamethasone Sodium Phosphate Injectiondrug